XML 37 R27.htm IDEA: XBRL DOCUMENT v3.25.3
Organization and Summary of Significant Accounting Policies (Tables)
 9 Months Ended
Sep. 30, 2025
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
Schedule of Changes in our Estimated Warranty Reserve Changes in our estimated product warranty liabilities were as follows (in thousands):
Nine Months Ended September 30,
20252024
Balance, beginning of period$8,284 $7,374 
Utilization of reserve(6,757)(5,007)
Warranty expense9,378 4,860 
Balance, end of period$10,905 $7,227 
Schedule of Weighted Average Number of Shares Outstanding and Earnings Per Share
The calculation of the weighted average number of shares outstanding and earnings per share is as follows (in thousands except per share data):
Three Months Ended September 30,Nine Months Ended September 30,
2025202420252024
Numerator for basic and diluted earnings per share:
Net income (loss)$(2,186)$67,025 $121,911 $241,850 
Denominator:  
Weighted average shares outstanding78,416 75,697 77,774 75,543 
Dilutive effect of stock-based awards— 1,317 1,846 1,298 
Dilutive effect of 2027 Notes (1)
— 1,015 1,092 773 
Dilutive effect of 2027 Warrants— 51 1,506 — 
Diluted weighted average shares outstanding78,416 78,080 82,218 77,614 
Net income (loss) per common share:
Basic$(0.03)$0.89 $1.57 $3.20 
Diluted$(0.03)$0.86 $1.48 $3.12 
(1)For the nine months ended September 30, 2025, the impact of the early repurchase of a portion of the 2027 Notes is weighted based upon the number of days in each corresponding period of time for (a) the period between January 1, 2025 and the closing date of the repurchase, which includes the total amount of shares issuable upon a conversion of all of the 2027 Notes; and (b) subsequent to the closing date of the repurchase through September 30, 2025, which includes the amount of shares issuable upon a conversion of the 2027 Notes that remain outstanding after the early repurchase. Refer to Note 10 for additional details.
Schedule of Potentially Dilutive Securities Excluded in Calculation of Diluted Net Income Per Share
Potentially dilutive securities that are not included in the calculation of diluted net income (loss) per share because doing so would be antidilutive are as follows (in thousands):
Three Months Ended September 30,Nine Months Ended September 30,
2025202420252024
Stock-based awards5,138 4,574 3,299 4,620 
2027 Notes1,235 2,002 401 2,244 
2027 Warrants3,017 2,966 1,511 3,017 
Total potentially dilutive securities9,390 9,542 5,211 9,881